Ilaria Penna Selected Research

Ilaria Penna Research Topics

5	Neoplasms (Cancer) 03/2022 - 12/2015
3	Neuroblastoma 12/2020 - 12/2015
2	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 03/2013
2	Melanoma (Melanoma, Malignant) 01/2016 - 09/2014
1	Cystic Fibrosis (Mucoviscidosis) 10/2020
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020
1	Burns 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Inflammation (Inflammations) 12/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2014
1	Breast Neoplasms (Breast Cancer) 11/2010

3	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 09/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2022
1	Glycogen Synthase Kinase 3 betaIBA 03/2022
1	OxazolesIBA 12/2020
1	Chloride Channels (Chloride Channel)IBA 10/2020
1	benzoxazoloneIBA 01/2020
1	piperidineIBA 01/2020
1	PolymersIBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	RNA Polymerase IIIIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2016
1	CaspasesIBA 01/2016
1	Effector CaspasesIBA 01/2016
1	Differentiation AntigensIBA 12/2015
1	perhexiline maleateIBA 12/2015
1	Untranslated RNA (Noncoding RNA)IBA 12/2015
1	Cisplatin (Platino)FDA LinkGeneric 12/2015
1	CeramidesIBA 12/2015
1	LipidsIBA 12/2015
1	Phosphotransferases (Kinase)IBA 09/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2014
1	tyrosine receptor (receptor, tyrosine)IBA 09/2014
1	TOR Serine-Threonine KinasesIBA 09/2014
1	Histone Deacetylase InhibitorsIBA 09/2014
1	MitogensIBA 09/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2014
1	Apoptosis Regulatory ProteinsIBA 09/2014
1	Death Domain ReceptorsIBA 09/2014
1	sortilinIBA 03/2013
1	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 11/2010

2	Therapeutics 01/2016 - 09/2014
1	Oral Administration 12/2020